Loading clinical trials...
Loading clinical trials...
Clinical Study of Cord Blood Derived CAR-T Cells in Patients With Refractory/Relapsed B Cell Leukemia/Lymphoma Who Are Failed for Autologous CAR-T Cells or Autologous CAR-T Can Not be Prepared
Conditions
Interventions
CAR-T cells
Locations
2
China
Henan Cancer Hospital
Zhengzhou, Henan, China
Henan Cancer Hospital
Zhengzhou, Henan, China
Start Date
February 27, 2019
Primary Completion Date
January 31, 2021
Completion Date
January 31, 2022
Last Updated
March 21, 2019
NCT05053971
NCT05039801
NCT06189391
NCT04973605
NCT07350863
NCT05006716
Lead Sponsor
Henan Cancer Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions